{"retracted":false,"update":{"timestamp":1426723200000,"doi":"10.1007/s12032-015-0482-5","type":"correction"},"doi":"10.1007/s12032-014-0460-3","journal":"Medical Oncology","publisher":"Springer Nature","title":"Erratum to: Single-agent bevacizumab is an effective treatment in recurrent glioblastoma"}
